Cardiovascular risk and prostanoids in systemic sclerosis

Clinical and Experimental Rheumatology

Volumn 26, Issue 2, 2008, Pages 333-336

  Colaci, Michele ^a   Sebastiani, Marco ^a   Giuggioli, Dilia ^a   Manfredi, Andreina ^a   Rossi, Rosario ^a   Modena, Maria Grazia ^a   Ferri, Clodoveo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Alprostadil; Cardiovascular risk; Iloprost; Prostanoids; Raynaud's; Scleroderma; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; ILOPROST; PROSTAGLANDIN E1; PROSTANOID; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG RESPONSE; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INTESTINE INFARCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SCLERODERMA; SKIN ULCER; STROKE; SYSTEMIC SCLEROSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ALPROSTADIL; FEMALE; HUMANS; ILOPROST; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RAYNAUD DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; SCLERODERMA, SYSTEMIC; STROKE; VASODILATOR AGENTS;

EID: 43349086722     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. FERRI C, VALENTINI G, COZZI F et al.: Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc) Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore). 2002; 81: 139-53.
2. LEROY EC, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
3. FERRI C, GIUGGIOLI D, SEBASTIANI M, COLACI M, EMDIN M: Heart involvement and systemic sclerosis. Lupus 2005; 14: 702-7.
4. FOLLANSBEE WPC Organ involvement: cardiac. In CLEMENTS PJ, FURST DE (Eds). Systemic sclerosis. Baltimore, Lippincott 1996: 333-64.
5. COGHLAN GJ, MUKERJEE D: The heart and pulmonary vasculature in scleroderma: Clinical features and pathobiology. Curr Opin Rheumatol 2001; 13: 495-9.
6. DERK CT, JIMENEZ SA: Acute myocardial infarction in Systemic Sclerosis patients: A case series. Clin Rheum 2007; 26: 965-8.
7. HUMMERS LK, WIGLEY FM: Management of Raynaud's phenomenon and digital ischemic lesions in scleroderma Rheum Dis Clin N Am 2003; 29: 293-313.
8. BUGIARDINI R, GALVANI M, FERRINI D et al.: Myocardial ischemia during intravenous prostacyclin administration: Hemodynamic findings and precautionary measures. Am Heart J 1987; 113: 234-40.
9. WHO, INTERNATIONAL SOCIETY OF HYPERTENSION WRITING GROUP: 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertension 2003; 21: 1983-92.
10. DORMANDY JA: Prostanoid drug therapy for peripheral arterial occlusive disease - the European experience. Vasc Med 1996; 1: 155-8.
11. MARASINI B, MASSAROTTI M, BOTTASSO B et al.: Comparison between iloprost and alprostadil in the treatment of Raynaud's phenomenon. Scand J Rheumatol 2004; 33: 253-6.
12. KAUKINEN S, YLITALO P, PESSI T, VAPAATALO H: Hemodynamic effects of iloprost, a prostacyclin analog. Clin Pharmacol Ther 1984; 36: 464-9.
13. RADEMAKER M, THOMAS RH, PROVOST G, BEACHAM JA, COOKE ED, KIRBY JD: Prolonged increase in digital blood flow following iloprost infusion in patients with systemic sclerosis. Postgrad Med J 1987; 63: 617-20.
14. TEDESCHI A, MERONI PL, DEL PAPA N, SALMASO C, BOSCHETTI C, MIADONNA A: Thrombotic events in patients with systemic sclerosis treated with iloprost. Arthritis Rheum 1998; 41: 559-62.
15. BRAUN J, SIEPER J, RIEMEKASTEN G, HIEPE F: Iloprost treatment in systemic sclerosis: Comment on the concise communication by Tedeschi et al. Arthritis Rheum 1999; 42: 196-8.
16. FAGGIOLI P, GIANI L, MAZZONE A: Possible role of iloprost (stable analog of PG12) in promoting neoangiogenesis in systemic sclerosis. Clin Exp Rheumatol 2006; 24: 220-1.